Clinical Trial: Thought Field Therapy and Cognitive Therapy for Agoraphobia

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: Thought Field Therapy and Cognitive Therapy for Agoraphobia - a Randomized Controlled Intervention Study Where the Efficacy of Thought Field Therapy is to be Compared to C

Brief Summary: The purpose for this study is to find out if Thought field therapy has the same effect as, or better effect than, Cognitive therapy for Agoraphobia.

Detailed Summary:

Thought field therapy is an alternative treatment method that has shown, by casuistic reports, to give good results when applied for anxiety disorders. In this study 72 patients will be randomized to three groups. 24 patients will receive cognitive therapy as a control method, 24 patients will receive thought field therapy. The remaining 24 patients will wait three months, and then be randomized to either of the two therapies.

Before inclusion all patients will be diagnosed with M.I.N.I. and SCID II. They will fill out self evaluation forms for symptoms and quality of life, before and after treatment, and one year after treatment.

All patients will undergo an interview with ADIS on panic and agoraphobic diagnosis and symptoms before starting treatment, and on panic and agoraphobic symptoms immediately after and one year after treatment. These interviews will be done by psychologists who are blinded for which type of treatment the patients have got.


Sponsor: Sorlandet Hospital HF

Current Primary Outcome: Change in agoraphobic situation scores in ADIS. [ Time Frame: Immedeately and 12 months after treatment ]

Original Primary Outcome: Same as current

Current Secondary Outcome:

  • Interference score in ADIS [ Time Frame: Immediately and 12 months after treatment ]
  • Mobility Inventory [ Time Frame: Immediately and 12 months after treatment ]
  • Agoraphobic Cognitions Questionnaire [ Time Frame: Immediately and 12 months after treatment ]
  • Body Sensations Questionnaire [ Time Frame: Immediately and 12 months after treatment ]
  • BDI [ Time Frame: Immediately and 12 months after treatment ]
  • BAI [ Time Frame: Immediately and 12 months after treatment ]
  • WHOQOL-BREF [ Time Frame: Immediately and 12 months after treatment ]
  • SF-36 [ Time Frame: Immediately and 12 months after treatment ]
  • Safety Seeking Behaviours Questionnaire. [ Time Frame: Immediately and 12 months after treatment ]
  • Panic scale [ Time Frame: Immediately and 12 months after treatment ]


Original Secondary Outcome: Same as current

Information By: Sorlandet Hospital HF

Dates:
Date Received: July 3, 2009
Date Started: October 2006
Date Completion:
Last Updated: April 22, 2014
Last Verified: April 2014